Comparing the efficacy of peripheral nerve blocks and injections within the knee for pain management following Total Knee Replacement

Randomized control trial to assess the efficacy of a single dose adductor canal block along with intra articular intermittent Ropivacaine infiltration using an epidural catheter, vs that of a Continuous adductor canal block for relief of post operative pain following Total Knee Arthroplasty

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2019/11/021861

Enrollment

120

Registered

2019-11-04

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M170- Bilateral primary osteoarthritis of knee

Interventions

Intervention1: Continuous Adductor Canal Block: Continuous Adductor Canal Block is given post operatively to patients following Total Knee Arthroplasty for post operative pain relief Control Intervent

Eligibility

Inclusion criteria

Inclusion criteria: All patients undergoing unilateral Total Knee Arthoplasty for primary osteoarthritis of the knee

Exclusion criteria

Exclusion criteria: Patients undergoing bilateral surgery Patients undergoing unicondylar knee arthoplasty Patients undergoing Totalkneearthoplasty for inflammatory aetiology Patients with bleeding diathesis Patients with renalfailure/elevated renal parameters Patients with pre-existing neuropathies Patients who have undergone any prior surgery to the affected limb

Design outcomes

Primary

Measure	Time frame
Visual Analog Scale of more than 6Timepoint: Visual Analog Scale of more than 6 at 6 hours, 12 hours, 24 hours, 48 hours post opeatively	—

Secondary

Measure	Time frame
Knee range of movement post operativelyTimepoint: At 48 hours post operatively	—

Countries

India

Contacts

Public ContactDr Uppada Prasanth

Maxcure Hospital

prashanth11135@gmail.com6303393068

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026